U.S. Physical Therapy, Inc.
USPH
$77.33
-$0.02-0.03%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.42% | 14.12% | 9.31% | 8.49% | 3.50% |
| Total Other Revenue | 27.00% | 30.14% | 26.90% | 21.23% | 12.19% |
| Total Revenue | 18.11% | 16.56% | 12.01% | 10.37% | 4.80% |
| Cost of Revenue | 19.29% | 18.78% | 10.97% | 11.80% | 4.73% |
| Gross Profit | 13.68% | 11.29% | 16.47% | 5.14% | 5.04% |
| SG&A Expenses | 15.34% | 12.01% | 19.40% | 17.32% | 1.63% |
| Depreciation & Amortization | 42.60% | 19.34% | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.54% | 18.15% | 11.74% | 12.32% | 7.39% |
| Operating Income | 4.29% | 3.45% | 14.26% | -2.24% | -15.03% |
| Income Before Tax | 17.43% | 17,184.91% | -21.82% | -22.52% | 2.50% |
| Income Tax Expenses | 22.97% | 316.58% | -28.06% | -27.13% | 5.73% |
| Earnings from Continuing Operations | 15.93% | 1,066.28% | -20.00% | -21.21% | 1.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.06% | -266.75% | -6.10% | -6.62% | 11.10% |
| Net Income | 23.03% | 1,309.15% | -28.38% | -31.26% | 8.58% |
| EBIT | 4.29% | 3.45% | 14.26% | -2.24% | -15.03% |
| EBITDA | 12.90% | 10.34% | 13.52% | 1.00% | -10.81% |
| EPS Basic | 71.58% | 236.93% | -23.85% | -27.03% | -19.32% |
| Normalized Basic EPS | -16.96% | -52.84% | 15.46% | -8.71% | -9.48% |
| EPS Diluted | 71.58% | 236.93% | -23.85% | -27.03% | -19.32% |
| Normalized Diluted EPS | -16.96% | -52.84% | 15.46% | -8.71% | -9.48% |
| Average Basic Shares Outstanding | 0.77% | 0.68% | 0.60% | 9.85% | 15.29% |
| Average Diluted Shares Outstanding | 0.77% | 0.68% | 0.60% | 9.85% | 15.29% |
| Dividend Per Share | 2.27% | 2.33% | 2.33% | 2.33% | 2.33% |
| Payout Ratio | -- | -0.93% | 0.44% | 0.72% | -- |